Basics |
Akero Therapeutics, Inc.
|
IPO Date: |
July 17, 2019 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$4.27B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.77 | 2.88%
|
Avg Daily Range (30 D): |
$1.38 | 3.12%
|
Avg Daily Range (90 D): |
$1.22 | 2.81%
|
Institutional Daily Volume |
Avg Daily Volume: |
.52M |
Avg Daily Volume (30 D): |
1.58M |
Avg Daily Volume (90 D): |
1.13M |
Trade Size |
Avg Trade Size (Sh.): |
66 |
Avg Trade Size (Sh.) (30 D): |
61 |
Avg Trade Size (Sh.) (90 D): |
57 |
Institutional Trades |
Total Inst.Trades: |
2,347 |
Avg Inst. Trade: |
$2.51M |
Avg Inst. Trade (30 D): |
$3.67M |
Avg Inst. Trade (90 D): |
$3.3M |
Avg Inst. Trade Volume: |
.08M |
Avg Inst. Trades (Per Day): |
2 |
Market Closing Trades |
Avg Closing Trade: |
$3.79M |
Avg Closing Trade (30 D): |
$8.26M |
Avg Closing Trade (90 D): |
$6.97M |
Avg Closing Volume: |
118.68K |
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-3.75
|
$-.9
|
$-.99
|
Diluted EPS
|
$-3.75
|
$-.9
|
$-.99
|
Revenue
|
$
|
$
|
$
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -269.44M
|
$ -70.73M
|
$ -70.02M
|
Operating Income / Loss
|
$ -306.35M
|
$ -80.88M
|
$ -78.03M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -437.93M
|
$ -154.32M
|
$ 24.17M
|
PE Ratio
|
|
|
|
|
|
|